Dimethyl Fumarate — Discount Pricing
Dimethyl Fumarate is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Dimethyl Fumarate Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $265.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Dimethyl Fumarate
Dimethyl Fumarate is a prescription medication. Ask your doctor if Dimethyl Fumarate is right for you.
How to Check Dimethyl Fumarate Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Dimethyl Fumarate at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Neurological
About Dimethyl Fumarate
Dimethyl fumarate is a widely prescribed oral medication for managing multiple sclerosis, helping patients live fuller lives. Understanding this treatment is key, and at TheDrugClub, we're dedicated to helping our members access significant savings on vital prescriptions like dimethyl fumarate, ensuring care is more accessible and affordable for you.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Dimethyl Fumarate is approved for (FDA label)
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: June 3, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.